Science to practice: Will gadolinium-enhanced MR imaging be useful in assessment of at-risk pregnancies?

Richard W Katzberg, John P McGahan

Research output: Contribution to journalArticle

13 Scopus citations


By assessing the maternofetal pharmacokinetics of a nonspecific extracellular gadolinium chelate in pregnant mice, Mühler et al(1)have shown that exposure to small amounts of a gadolinium chelate after injection in the mother is a reversible phenomenon, thereby reducing fetal exposure. These results have encouraging implications for the safety of contrast material-enhanced magnetic resonance(MR) imaging during human pregnancy in the third trimester.

Original languageEnglish (US)
Pages (from-to)325-326
Number of pages2
Issue number2
StatePublished - Feb 2011


ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this